Rockefeller Capital Management’s Vicarious Surgical RBOT Stock Holding History

Rockefeller Capital Management’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-884	Closed	-$636	–	4848
2026 Q1	$636	Hold	884	–	–	﹤0.01%	4544
2025 Q4	$1.92K	Buy	884 +468	+113%	+$1.9K	﹤0.01%	4332
2025 Q3	$2.29K	Buy	+416	New	+$3.18K	﹤0.01%	4061
2023 Q1	–	Sell	-183	Closed	-$11K	–	3471
2022 Q4	$11K	Hold	183	–	–	﹤0.01%	3049
2022 Q3	$18K	Hold	183	–	–	﹤0.01%	2827
2022 Q2	$16K	Sell	183 -167	-48%	-$20.4K	﹤0.01%	2870
2022 Q1	$53K	Buy	350 +50	+17%	+$9.3K	﹤0.01%	2281
2021 Q4	$95K	Buy	300 +167	+126%	+$58.9K	﹤0.01%	1963
2021 Q3	$59K	Buy	+133	New	+$42.1K	﹤0.01%	2065

Other funds holding RBOT

KGAL

K5 Global Advisor LLC Miami Beach, Florida $6.59B AUM

Rockefeller Capital Management's RBOT Position: Q2 2026 in Review

Rockefeller Capital Management sold out of Vicarious Surgical (RBOT) in Q2 2026, closing a stake of 884 shares — an estimated $636 sold.

Rockefeller Capital Management first reported a position in RBOT in Q3 2021 and held it in 9 quarters. The position peaked at $95K in Q4 2021. 1 fund tracked by Wall St. Rank holds RBOT as of Q2 2026.

Rockefeller Capital Management reported no remaining Vicarious Surgical position as of Q2 2026 after selling out during the quarter.
Rockefeller Capital Management sold 884 Vicarious Surgical shares in Q2 2026, an estimated $636.
Rockefeller Capital Management first reported a position in Vicarious Surgical in Q3 2021 and held it in 9 quarters.
Rockefeller Capital Management's Vicarious Surgical position peaked at $95K in Q4 2021.
1 fund tracked by Wall St. Rank held Vicarious Surgical as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.